论文信息 - Dose of contrast material in the MR imaging evaluation of central nervous system tumors - 字舞流文

Dose of contrast material in the MR imaging evaluation of central nervous system tumors

Keywords: Brain neoplasms, diagnosis, 10.12143; Brain neoplasms, MR, 10.12143; Contrast enhancement; Nervous system, MR, 10.12143; Nervous system, neoplasms, 10.12143

W. Yuh | N. Mayr | D. Fisher | T. Simonson | H. Nguyen | J. I. Halloran | Hoang D. Nguyen | D. Fisher | Teresa M. Simonson | T. Simonson

[1] S. Wall,et al. Gastrointestinal tract in the immunocompromised host: opportunistic infections and other complications. , 1992, Radiology.

[2] V. Runge,et al. High‐dose gadoteridol in MR imaging of intracranial neoplasms , 1992, Journal of magnetic resonance imaging : JMRI.

[3] W G Bradley,et al. Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine. , 1991, Radiology.

[4] P. Hudgins,et al. Pituitary adenoma: correlation of half-dose gadolinium-enhanced MR imaging with surgical findings in 26 patients. , 1991, Radiology.

[5] J. Ehrhardt,et al. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. , 1991, Radiology.

[6] M. Mafee,et al. Neuroradiologic evaluation of patients with central auditory lesions. , 1985, Otolaryngologic clinics of North America.